Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study-Reference-Cited by-同舟云学术

Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study

Published:2024-02-27 Issue:4 Volume:38 Page:887-892
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Junk Stefanie V.^ORCID,Förster Alisa,Schmidt Gunnar,Zimmermann Martin^ORCID,Fedders Birthe,Haermeyer Bernd,Bergmann Anke K.^ORCID,Möricke Anja,Cario Gunnar,Auber Bernd,Schrappe Martin^ORCID,Kratz Christian P.^ORCID,Stanulla Martin^ORCID

Funder

Wilhelm Sander-Stiftung

Deutsche Krebshilfe

TRANSCALL2, ERA-NET TRANSCAN/European Commission under the 7th Framework Programme (FP7), Verein für krebskranke Kinder Hannover e.V., Deutsche José Carreras Leukämie-Stiftung

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02173-2.pdf

Reference15 articles.

1. Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33:2938–48.

2. Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24:265–84.

3. Schmiegelow K, Levinsen MF, Attarbaschi A, Baruchel A, Devidas M, Escherich G, et al. Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. J Clin Oncol. 2013;31:2469–76.

4. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA. 2007;297:1207–15.

5. Moricke A, Zimmermann M, Valsecchi MG, Stanulla M, Biondi A, Mann G, et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood. 2016;127:2101–12.